Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NanoString Technologies, Inc. of $230 million aggregate principal amount of its 2.625% convertible senior notes due 2025, which included $30 million aggregate principal amount of notes issued pursuant to the full exercise of the initial purchasers’ option to purchase additional notes.
Headquartered in Seattle, Washington, NanoString Technologies, Inc. is a leading provider of life science tools for translational research, focusing on developing, manufacturing and selling products that unlock scientifically valuable and clinically actionable information from minute amounts of biological material.
The Davis Polk corporate team included partner Alan F. Denenberg, counsel Jeffrey Gould and associates Benson Richards and Travis B. Mitchell. Partner Po Sit and associate Ben Levenback provided tax advice. Partner Pritesh P. Shah and associate Yifu Chen provided intellectual property advice. Members of the Davis Polk team are based in the Northern California and New York offices.